Noticed that as of now GSK hasn't displaced any Oncology Reps in preparation for the transition. Is this the same at Novartis or have they already started making cuts to Vaccines reps?
I don't think so, but there are several vaccine representatives who are not working but still getting paid.
With Vaccines sales performance, that fact is that the majority have always gotten paid fro not working.
Terms of the deal are they cannot touch headcount in a negative way ahead of the closing of the deal. Once the deal closes, either side can do whatever they want with their new staff. Once the ink is dry, the layoffs will come fast and hard